Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             60 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial Earl, Helena M

18 6 p. 755-769
artikel
2 Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study Atkin, Wendy

18 6 p. 823-834
artikel
3 Adopting a new stance on immunotherapy for uveal melanoma Komatsubara, Kimberly M

18 6 p. 702-704
artikel
4 A new standard of care or just another option for patients with relapsed ovarian cancer? Harter, Philipp

18 6 p. 701-702
artikel
5 Art and emotion in health care Zektzer, Carly

18 6 p. 716
artikel
6 Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial Coleman, Robert L

18 6 p. 779-791
artikel
7 Brigatinib effective in ALK-positive non-small-cell lung cancer Das, Manjulika

18 6 p. e310
artikel
8 Cancer Drugs Fund of minimal benefit Burki, Talha Khan

18 6 p. e305
artikel
9 Cancer Rhapsody Mariotti, Laura

18 6 p. 715
artikel
10 Can post-polypectomy surveillance be less intensive? Winawer, Sidney J

18 6 p. 707-709
artikel
11 CAR T-cell therapy effective in B acute lymphoblastic leukaemia Wang, Mai

18 6 p. e314
artikel
12 Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer Carvalho, Carlos

18 6 p. e354-e363
artikel
13 Chernobyl's tomb Burki, Talha Khan

18 6 p. 718
artikel
14 Correction to Lancet Oncol 2017; 18: 719–31
18 6 p. e301
artikel
15 Correction to Lancet Oncol 2017; 18: 63–74
18 6 p. e301
artikel
16 Correction to Lancet Oncol 2017; 18: 812
18 6 p. e301
artikel
17 Cracking the cancer code: a personalised genomic approach Lucas, Catherine

18 6 p. 717
artikel
18 Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? Shah, Ravi M

18 6 p. e291
artikel
19 Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? – Authors' reply Schmiegelow, Kjeld

18 6 p. e292
artikel
20 Electronic cigarette use in the UK Burki, Talha Khan

18 6 p. e311
artikel
21 European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Weller, Michael

18 6 p. e315-e329
artikel
22 European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma Pace, Andrea

18 6 p. e330-e340
artikel
23 European Association for the Study of the Liver: International Liver Congress 2017 Meeting Fricker, Janet

18 6 p. 713
artikel
24 Evolving adoptive cellular therapies in urological malignancies Wong, Yien Ning Sophia

18 6 p. e341-e353
artikel
25 Evolving health-care regulations in China Ouyang, Yadan

18 6 p. 714
artikel
26 “Finding NEMO” in NRAS-mutant melanoma: a step towards a sequential strategy? Bersanelli, Melissa

18 6 p. e298
artikel
27 Genetics of gallbladder cancer Hemminki, Kari

18 6 p. e296
artikel
28 Genetics of gallbladder cancer – Authors' reply Mhatre, Sharayu

18 6 p. e297
artikel
29 Glio, and the family Stone Morgan, Jules

18 6 p. 715
artikel
30 Graphing individual cancer experiences with Cancergraph Jenkins, Emily

18 6 p. 718
artikel
31 Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial Gronchi, Alessandro

18 6 p. 812-822
artikel
32 HPV-related oropharyngeal carcinoma de-escalation protocols Mesía, Ricard

18 6 p. 704-705
artikel
33 Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement Denburg, Avram

18 6 p. 709-711
artikel
34 Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? Zandee, Wouter T

18 6 p. e299
artikel
35 Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? – Authors' reply Halperin, Daniel M

18 6 p. e300
artikel
36 International incidence of childhood cancer, 2001–10: a population-based registry study Steliarova-Foucher, Eva

18 6 p. 719-731
artikel
37 Malignancy in a child or something else? Hoyer-Kuhn, Heike

18 6 p. e364
artikel
38 Naldemedine effective in treating opioid-induced constipation Brower, Vicki

18 6 p. e306
artikel
39 Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here? van der Graaf, Winette T A

18 6 p. 706-707
artikel
40 Neoadjuvant chemotherapy: survival benefit in gastric cancer Das, Manjulika

18 6 p. e307
artikel
41 New drug-transfer device reduces hazardous exposure Gourd, Elizabeth

18 6 p. e312
artikel
42 Pfizer to make palbociclib temporarily free on NHS Burki, Talha Khan

18 6 p. e309
artikel
43 Pregnancy complications in survivors of childhood cancer Brower, Vicki

18 6 p. e303
artikel
44 Preventing prevention: Indian politics and public health clash The Lancet Oncology,

18 6 p. 695
artikel
45 Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study Chen, Allen M

18 6 p. 803-811
artikel
46 Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial Alistar, Angela

18 6 p. 770-778
artikel
47 Selumetinib does not improve survival outcomes in NSCLC Das, Manjulika

18 6 p. e313
artikel
48 Short-course radiotherapy with delayed surgery for rectal cancer Xie, Li

18 6 p. e294
artikel
49 Short-course radiotherapy with delayed surgery for rectal cancer Kurokawa, Tomohiro

18 6 p. e293
artikel
50 Short-course radiotherapy with delayed surgery for rectal cancer – Authors' reply Erlandsson, Johan

18 6 p. e295
artikel
51 Switch to exemestane effective in early breast cancer Gourd, Elizabeth

18 6 p. e308
artikel
52 Targeting metabolism in pancreatic cancer Michalski, Christoph W

18 6 p. 699-700
artikel
53 The tAnGo fell short of inspiring the audience Mavroudis, Dimitrios

18 6 p. 698-699
artikel
54 Trastuzumab emtansine in HER2-positive metastatic breast cancer Montemurro, Filippo

18 6 p. 696-697
artikel
55 Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial Diéras, Véronique

18 6 p. 732-742
artikel
56 Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial Krop, Ian E

18 6 p. 743-754
artikel
57 Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study Chandran, Smita S

18 6 p. 792-802
artikel
58 Treatment options for early-stage Hodgkin's lymphoma Venkatesan, Priya

18 6 p. e304
artikel
59 Tyrosine kinase-inhibitors and heart failure risk Das, Manjulika

18 6 p. e302
artikel
60 Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer Tseng, Jennifer

18 6 p. 711-712
artikel
                             60 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland